Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $33.5200 (-12.37%) ($33.2600 - $38.1800) on Thu. Dec. 20, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.32% (three month average) | RSI | 35 | Latest Price | $33.5200(-12.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -4.5% a day on average for past five trading days. | Weekly Trend | ATRA declines -3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(58%) ARKG(51%) IBB(50%) IWO(50%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -2.16% in a week (0% probabilities). VXX(-14%) TLT(-14%) VIXM(-13%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.16% (StdDev 4.32%) | Hourly BBV | 0 () | Intraday Trend | -12.2% | | | |
|
Resistance Level | $39.96 | 5 Day Moving Average | $38.46(-12.84%) | 10 Day Moving Average | $40.16(-16.53%) | 20 Day Moving Average | $39.96(-16.12%) | To recent high | -22.9% | To recent low | 6% | Market Cap | $2.491b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |